Ritiometan
- Level
- Commodity
- Parent
- 51473700
- Below
- 0
- Links · KBLI
- 10
Definition
UNSPSC 51473703This classification denotes an anti-infective agent with the molecular formula C7H10O6S3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier J89LM8QVEE, chemically known as 2,2,2-(methylidynetris(thio))trisacetic acid but more generally known as ritiometan, which bears U.S. National Institutes of Health Compound Identifier 65787. The European Medicines Agency schedules Ritiometan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10338MIG. The term RITIOMETAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 1, No. 4, 1987, List 27). The World Health Organization schedules ritiometan in its Anatomical Therapeutic Chemical (ATC) Classification. RITIOMETAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(C(SCC(=O)O)SCC(=O)O)CC(=O)O.
Same parent
Under 51473700 · 4Activities that produce or sell this
KBLI · 10Inherited from family 51470000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.